6-Methyl-3-nitro-2(5H)-pyridinone
Common Name: |
6-Methyl-3-nitro-2(5H)-pyridinone |
IUPAC Name: |
(4R,5R)-2-hydroxy-3,4,5-trimethylcyclopent-2-en-1-one |
Molecular Formula: |
C8H12O2 |
SMILES: |
C[C@@H]1[C@H](C(=O)C(=C1C)O)C |
Inchi: |
1S/C8H12O2/c1-4-5(2)7(9)8(10)6(4)3/h4-5,10H,1-3H3/t4-,5-/m1/s1 |
Inchi Key: |
RMXYMRMUZJILGN-RFZPGFLSSA-N |
Cas No: |
125476-23-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
140.18 |
Mass (g/mol) |
140.084 |
Molar Refractivity |
39.75 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
249.61 |
Vapor Pressure (mmHg@25.00 °C) |
0.004 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.62 |
LogP |
1.673 |
iLOGP |
1.76 |
XLOGP3 |
1.21 |
WLOGP |
1.67 |
MLOGP |
0.65 |
ESOL Log S |
-1.47 |
ESOL Solubility (mg/ml) |
4.73 |
ESOL Solubility (mol/l) |
0.034 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.59 |
Ali Solubility (mg/ml) |
3.6 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.23 |
Silicos-IT Solubility (mg/ml) |
8.33 |
Silicos-IT Solubility (mol/l) |
0.06 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.30 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.48 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.416 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |